CytRx (CYTR) – Analyst Ratings
-
UPDATE: H.C. Wainwright Starts CytRx Corp (CYTR) at Buy
-
FBR Affirms CytRx (CYTR) at 'Outperform' Following Strong Aldoxorubicin Phase 1b/2 Data
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to CYTR Stock Lookup